Ameriprise Financial Inc. Acquires New Shares in Phreesia, Inc. (NYSE:PHR)

Ameriprise Financial Inc. acquired a new stake in shares of Phreesia, Inc. (NYSE:PHR - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 10,675 shares of the company's stock, valued at approximately $269,000.

Other institutional investors also recently bought and sold shares of the company. Charles Schwab Investment Management Inc. boosted its holdings in shares of Phreesia by 10.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock valued at $12,415,000 after acquiring an additional 46,209 shares during the last quarter. Barclays PLC boosted its holdings in shares of Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company's stock valued at $2,163,000 after acquiring an additional 43,225 shares during the last quarter. Proficio Capital Partners LLC purchased a new stake in shares of Phreesia during the 4th quarter valued at about $377,000. M&T Bank Corp boosted its holdings in shares of Phreesia by 56.4% during the 4th quarter. M&T Bank Corp now owns 54,939 shares of the company's stock valued at $1,382,000 after acquiring an additional 19,812 shares during the last quarter. Finally, Rhumbline Advisers lifted its stake in shares of Phreesia by 7.4% in the 4th quarter. Rhumbline Advisers now owns 83,631 shares of the company's stock worth $2,104,000 after purchasing an additional 5,756 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Phreesia news, CFO Balaji Gandhi sold 8,045 shares of Phreesia stock in a transaction on Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total transaction of $191,873.25. Following the completion of the transaction, the chief financial officer now directly owns 108,411 shares of the company's stock, valued at $2,585,602.35. The trade was a 6.91% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, General Counsel Allison C. Hoffman sold 3,496 shares of Phreesia stock in a transaction on Monday, March 17th. The stock was sold at an average price of $25.32, for a total transaction of $88,518.72. Following the transaction, the general counsel now directly owns 139,134 shares of the company's stock, valued at $3,522,872.88. The trade was a 2.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,474 shares of company stock worth $1,023,208 over the last quarter. Insiders own 5.50% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on PHR shares. DA Davidson lowered their price objective on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. KeyCorp lowered their price objective on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Wall Street Zen upgraded shares of Phreesia from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. Truist Financial increased their price objective on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research note on Thursday, May 29th. Finally, Citigroup reiterated a "buy" rating on shares of Phreesia in a research note on Wednesday, May 28th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat.com, Phreesia currently has a consensus rating of "Buy" and a consensus price target of $31.64.

Phreesia Stock Performance

NYSE PHR traded up $0.67 on Monday, reaching $27.48. 374,227 shares of the stock were exchanged, compared to its average volume of 439,522. Phreesia, Inc. has a one year low of $17.07 and a one year high of $30.53. The firm has a market capitalization of $1.64 billion, a PE ratio of -18.69 and a beta of 0.68. The company's 50-day simple moving average is $24.77 and its two-hundred day simple moving average is $25.61. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR - Get Free Report) last released its earnings results on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company had revenue of $115.94 million for the quarter, compared to analysts' expectations of $115.00 million. During the same quarter last year, the business earned ($0.05) EPS. The firm's revenue was up 14.5% compared to the same quarter last year. Analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.